Exela Technologies, Inc. ( XELA) Stock. Should you Buy or Sell? $ 0.88
0.04 (4.47 %)
Exela Technologies, Inc. Analysis
Updated on 10-09-2022Symbol | XELA |
Price | $0.88 |
Beta | 1.717 |
Volume Avg. | $11.6 M |
Market Cap | $56.98 M |
52 Week Range | $0.785 - $47.6 |
Exela Technologies, Inc. opened the day at $0.88 which is +'4.47 % on yesterday's close. Exela Technologies, Inc. has a 52 week high of $47.6 and 52 week low of $0.785, which is a difference of $46.815. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $56.98 M and total net profit is $1166606000 which means the company is trading at 0.05 times profit to market capitalization. Theoretically, if you were to buy Exela Technologies, Inc. for $56.98 M, it would take 15 years to get your money back. Exela Technologies, Inc. are in the Software—Application space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
Exela Technologies, Inc. Stock Forecast - Is Exela Technologies, Inc. a Buy or Sell?
DCF Score | Strong Buy | |
ROE Score | Buy | |
ROA Score | Neutral | |
DE Score | Sell | |
PE Score | Strong Sell | |
PB Score | Strong Sell | |
Overall Recommendation | Neutral |
Growth and Value
PE Ratio | -0.932 |
Dividend Yiel | 0.000 |
Net Profit Margin | -0.166 |
Valuing Exela Technologies, Inc.
Price Book Value Ratio | -210.032 | Price To Book Ratio | -210.032 |
Price To Sales Ratio | 0.155 | Price Earnings Ratio | -0.932 |
How liquid is Exela Technologies, Inc.
Current Ratio | 0.452 |
Quick Ratio | 0.283 |
Debt
Debt Ratio | 1.650 | Debt Equity Ratio | -2.538 |
Long Term Debt To Capitalization | 2.605 | Total Debt To Capitalization | 2.173 |
Latest news about Exela Technologies, Inc.

Exela Technologies, Inc. (XELA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Exela Technologies prides itself as a leader in the field of business process management but analysis of its products and services shows otherwise. DrySign appears to be making notable expansion but size of current user base is still modest compared to alternative products.

Source: shutterstock.com/Peshkova Exela (NASDAQ: XELA ) stock is falling on Wednesday after the business process automation company reported preliminary results for the second quarter of 2022. The bad news for XELA stock starts with the company's adjusted earnings per share of -$3.22.

IRVING, Texas, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ:XELA), a global business process automation (“BPA”) leader across numerous industries, will host a conference call with the financial community to discuss results for the second quarter 2022 at 4:30 p.m. ET on August 9, 2022. Exela will issue a press release reporting its results before the start of the call.

Here's what you need to know about trading penny stocks on August 4th The post Best Penny Stocks to Buy Premarket on August 4th? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
About Exela Technologies, Inc.
Description :
Exela Technologies, Inc. provides transaction processing solutions, enterprise information management, document management, and digital business process services worldwide. The company operates through three segments: Information & Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal & Loss Prevention Services (LLPS). The ITPS segment provides lending solutions for mortgages and auto loans; banking solutions for clearing, anti-money laundering, sanctions, and interbank cross-border settlement; property and casualty insurance solutions for origination, enrollments, claims processing, and benefits administration communications; and public sector solutions for income tax processing, benefits administration, and records management. It also offers solutions for payment processing and reconciliation, integrated receivable and payables management, document logistics and location services, records management, and electronic storage of data/documents; and software, hardware, professional services, and maintenance related to information and transaction processing automation. The HS segment provides revenue cycle solutions, integrated accounts payable and accounts receivable, and information management for healthcare payer and provider markets. The LLPS segment processes legal claims for class action and mass action settlement administrations, involving project management support, notification, and outreach to claimants; and collects, analyzes, and distributes settlement funds. It also offers data and analytical services in the areas of litigation consulting, economic and statistical analysis, expert witness services, and revenue recovery services for delinquent accounts receivable. The company is headquartered in Irving, Texas.